Selected article for: "protease expression and serine protease expression"
Author: Nersisyan, Stepan; Shkurnikov, Maxim; Turchinovich, Andrey; Knyazev, Evgeny; Tonevitsky, Alexander
Title: Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2
  • Cord-id: f0txnc8u
  • Document date: 2020_7_29
    • ID: f0txnc8u
    Snippet: Development of novel approaches for regulating the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) is becoming increasingly important within the context of the ongoing COVID-19 pandemic since these enzymes play a crucial role in cell infection. In this work we searched for putative ACE2 and TMPRSS2 expression regulation networks mediated by various miRNA isoforms (isomiR) across different human organs using publicly available paired miRNA/mRNA-s
    Document: Development of novel approaches for regulating the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) is becoming increasingly important within the context of the ongoing COVID-19 pandemic since these enzymes play a crucial role in cell infection. In this work we searched for putative ACE2 and TMPRSS2 expression regulation networks mediated by various miRNA isoforms (isomiR) across different human organs using publicly available paired miRNA/mRNA-sequencing data from The Cancer Genome Atlas (TCGA) project. As a result, we identified several miRNA families targeting ACE2 and TMPRSS2 genes in multiple tissues. In particular, we found that lysine-specific demethylase 5B (JARID1B), encoded by the KDM5B gene, can indirectly affect ACE2 / TMPRSS2 expression by repressing transcription of hsa-let-7e / hsa-mir-125a and hsa-mir-141 / hsa-miR-200 miRNA families which are targeting these genes.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • absence presence and acute ards respiratory distress syndrome development: 1
    • absence presence and acute lung injury: 1, 2, 3
    • absence presence and additional experiment: 1, 2
    • absence presence and lung cancer: 1, 2, 3, 4
    • absence presence and lung cancer cell: 1
    • absence presence and lung cell infection: 1
    • absence presence and lung failure: 1, 2
    • absence presence and lung injury: 1, 2, 3, 4
    • absence presence and lung kidney: 1, 2, 3, 4
    • absence presence and lung parenchyma: 1
    • absence presence and lung tissue: 1, 2, 3, 4, 5, 6, 7, 8